Allworth Financial’s Mereo BioPharma MREO Stock Holding History

Allworth Financial’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$495	Sell	1,500 -111	-7%	-$48	﹤0.01%	4731
2025 Q4	$672	Buy	1,611 +38	+2%	+$72	﹤0.01%	4465
2025 Q3	$3.24K	Sell	1,573 -64	-4%	-$118	﹤0.01%	3786
2025 Q2	$4.44K	Buy	1,637 +137	+9%	+$331	﹤0.01%	3328
2025 Q1	$3.81K	Hold	1,500	–	–	﹤0.01%	2907
2024 Q4	$4.38K	Hold	1,500	–	–	﹤0.01%	2826
2024 Q3	$6.17K	Hold	1,500	–	–	﹤0.01%	2476
2024 Q2	$5.82K	Hold	1,500	–	–	﹤0.01%	2452
2024 Q1	$4.95K	Hold	1,500	–	–	﹤0.01%	2412
2023 Q4	$3.46K	Hold	1,500	–	–	﹤0.01%	2432
2023 Q3	$1.94K	Hold	1,500	–	–	﹤0.01%	2556
2023 Q2	$1.98K	Hold	1,500	–	–	﹤0.01%	2489
2023 Q1	$1.06K	Hold	1,500	–	–	﹤0.01%	2649
2022 Q4	$1.13K	Buy	+1,500	New	+$1.23K	﹤0.01%	2436

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $712M AUM

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Allworth Financial's MREO Position: Q1 2026 in Review

Allworth Financial reduced its Mereo BioPharma (MREO) stake by 6.9% in Q1 2026, selling an estimated $48 and leaving 1,500 shares worth $495. The position accounts for ﹤0.01% of the portfolio, ranked #4731.

Allworth Financial first reported a position in MREO in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.17K in Q3 2024. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

Allworth Financial held 1,500 shares of Mereo BioPharma worth $495 as of Q1 2026.
Allworth Financial sold 111 Mereo BioPharma shares in Q1 2026, an estimated $48.
Mereo BioPharma made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4731 holding.
Allworth Financial first reported a position in Mereo BioPharma in Q4 2022 and has held it in 14 quarters since.
Allworth Financial's Mereo BioPharma position peaked at $6.17K in Q3 2024.
63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.